KIMBERLY SPIVEY: Open Payments
NPI 1013280031 · AYNOR, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 51 payments from 15 companies in 2025. Trend: 2023 $347 · 2024 $1,210 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $271 |
| Novo Nordisk Inc | 8 | $180 |
| AstraZeneca Pharmaceuticals LP | 9 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $122 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| PFIZER INC. | 5 | $86 |
| Dexcom, Inc. | 3 | $67 |
| Exact Sciences Corporation | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $28 |
Products named: SPRAVATO, XIFAXAN, TRELEGY ELLIPTA, Wegovy, ELIQUIS, Dexcom G6 Transmitter, Rybelsus, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
